C2N Diagnostics
Elizabeth Wahl, PhD, MBA, is an accomplished professional currently serving as the Director of Product Management for New Products at C2N Diagnostics since June 2025. Prior experience includes roles such as Product Manager for Cell & Gene Therapy at Thermo Fisher Scientific, where responsibilities encompassed digital automation solutions and portfolio repositioning, and Strategic Product Manager at Gemini Bio. Elizabeth has a diverse background in scientific and product management roles across various organizations, including PromoCell, Enago, and the BALSA Group, and has supported research in tissue engineering at the Technical University of Munich. The educational qualifications include a PhD in Experimental Medicine from the Technical University of Munich, an MBA from the University of Illinois Urbana-Champaign, and degrees in Molecular Bioengineering and Biological Anthropology from institutions such as UC Irvine and Kent State University.
This person is not in any teams
This person is not in any offices
C2N Diagnostics
C2N Diagnostics, LLC is a privately held protein diagnostic and therapeutic discovery company.